Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 5,297 $ 28
Prepaid expenses 364 246
Total Current Assets 5,661 274
Deposits 0 12
Operating lease right-to use asset 0 110
TOTAL ASSETS 5,661 396
Current Liabilities:    
Accounts payable 2,243 1,940
Accrued expenses 1,296 2,379
Accrued interest 4,838 2,029
Convertible notes payable, of which $16.8 were past due at December 31, 2020 (net of discount of $4,519 and $91) 26,303 13,207
Operating lease liability 0 120
Line of credit 31 31
Derivative liability 383 0
Total Current Liabilities 35,094 19,706
Stockholders' (Deficit):    
Convertible preferred stock - $0.01 par value; 15,000,000 shares authorized 3 3
Common stock, par value $0.0001, 2,000,000,000 shares authorized, 5,218,122 and 4,104,982 shares issued and outstanding as of December 31, 2020 and 2019, respectively 52 41
Additional paid-in capital 566,309 548,147
Accumulated deficit (595,628) (567,332)
Noncontrolling interest (169) (169)
Total Stockholders' Deficit (29,433) (19,310)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 5,661 396
Series C    
Stockholders' (Deficit):    
Convertible preferred stock - $0.01 par value; 15,000,000 shares authorized 1 1
Series J    
Stockholders' (Deficit):    
Convertible preferred stock - $0.01 par value; 15,000,000 shares authorized $ 2 $ 2